Trials / Completed
CompletedNCT07333833
Development and Validation of an Early Prediction Model for Severe Mycoplasma Pneumoniae Pneumonia in Children
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 964 (actual)
- Sponsor
- Beijing Friendship Hospital · Academic / Other
- Sex
- All
- Age
- 1 Month – 14 Years
- Healthy volunteers
- Not accepted
Summary
Pneumonia is a major threat to the health of children. Mycoplasma pneumoniae infection is a core cause of pediatric pneumonia, and the incidence of severe mycoplasma pneumoniae pneumonia (SMPP) has increased in recent years. SMPP leads to a range of extrapulmonary symptoms, including myocardial and liver injury, which may be life-threatening. Therefore, there is an urgent need to establish an early warning model for SMPP to improve the prognosis of pediatric pneumonia. This observational study aims to establish a early prediction model of SMPP. Development cohorts are enrolled from Beijing Friendship Hospital between 2018-1-1 to 2024-5-31, and validation cohorts are enrolled between 2024-6-1 to 2025-6-30.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | medical history taking, blood test, pulmonary ultrasound | medical history taking, blood test, pulmonary ultrasound are used for MPP and SMPP diagnosis |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2025-06-30
- Completion
- 2025-06-30
- First posted
- 2026-01-12
- Last updated
- 2026-01-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07333833. Inclusion in this directory is not an endorsement.